Figure 4
From: Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts
(A) TNFα assay of GL-loaded NG/NP on LPS-induced monocytes. Results were expressed by concentration (pg/mL) as compared with control. Data represent mean ± SD (n = 3); (B) Expression levels of Caspase1, Caspase3, Caspase8, Caspase9, NLRP3, NOS, MYD88, IL-1beta and IL-18 for LPS primed monocytes exposed to nanoghosts (NG) and nanoparticles (NP) compared to LPS-primed monocytes. Data represent mean ± SD (n = 3). *P-value < 0.05.
